Apoglyx is a pre-clinical stage biotech company with the aim to develop a small molecule therapy for sepsis, and further indications, based on inhibition of Aquaporin-9. Apoglyx was founded based on research from Aarhus University (DK), Aalborg University (DK), and Lund University (S).
View Top Employees from ApoGlyxWebsite | http://www.apoglyx.com |
Employees | 5 (1 on RocketReach) |
Founded | 2015 |
Technologies |
JavaScript,
HTML,
PHP
+8 more
(view full list)
|
Industry | Biotechnology Research |
Looking for a particular ApoGlyx employee's phone or email?
Johan Evenäs is the Board Member of ApoGlyx.
1 people are employed at ApoGlyx.